Role of immunotherapy beyond advanced HCC

COR2ED Medical Education

Aug 17 2022 | 00:29:42

00:00 / 00:29:42

Show Notes

COR2ED Medical Education: In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced and early stage hepatocellular carcinoma (HCC). They focus on the role of immunotherapy and review data from three major congresses in 2022 (ASCO, WCGIC and ILC) together with recent publications.

Prof. Amit Singal is Director of Liver Cancer Program at UT Southwestern Medical Center, Dallas, TX, USA and Assoc. Prof. Neil Mehta is Director of Liver Cancer Program at University of California San Francisco, USA.

Other Episodes

Episode 3

February 10, 2022 • 00:26:43

PARP inhibitors in prostate cancer: Management of adverse events and the importance of communication with patients

COR2ED Medical Education: Dr Jason Alcorn, nurse consultant for Uro-Oncology & Andrology at the Mid Yorkshire Hospitals NHS Trust, United Kingdom and Dr Alicia...

Episode 1

May 12, 2021 • 00:30:53

Radiopharmaceuticals in prostate cancer - radium-223 episode 1

Dr. Tanya Dorff (City of Hope Comprehensive Cancer Center, Los Angeles, USA) and Dr. Phillip Koo (Banner MD Anderson Cancer Center, Arizona, USA) discuss...

Episode 24

October 11, 2023 • 00:35:29

IUD Placement: How to Reduce Anxiety and Pain for Patients

COR2ED Medical Education: Welcome to the "Addressing Anxiety and Pain Around IUD Placement" podcast, where experts in the field, Carolyn Westhoff MD, Michal Yaron...